Addition of manual daytime exchanges to automated peritoneal dialysis (APD) regimens optimizes solute clearance, but reduces quality of life and might increase the risk of peritonitis. Clinically ...

The US Food and Drug Administration (FDA) has cleared Baxter International's AMIA automated home peritoneal dialysis (APD) system with remote connectivity over the Internet, using the company's ...

Peritoneal dialysis (PD) continues its slow march toward equal popularity within the nephrology community. In most areas of the United States, it is still the minority to the behemoth that is ...

First patients have been enrolled in the clinical trial for next generation dialysis technology Innovative system designed to improve home dialysis experience and simplify therapy management New ...

For most people, hemodialysis and peritoneal dialysis are equally effective treatments for end stage renal disease. Factors such as your health, preferences, and the costs may influence your final ...

KIDNEY substitutes that are effective in the management of chronic renal failure are hemodialysis and peritoneal dialysis. Scribner's technic for hemodialysis developed in 1958–59, 1 employing an ...

Kidney disease affects millions globally, often reducing quality of life and daily functioning. In the United States, about 14% of adults have chronic kidney disease (CKD), according to the National ...

Baxter has received clearance from the FDA for the latest version of its automated peritoneal dialysis system designed for home use, combining it with a digital platform that aims to help patients ...

In 2008, an estimated 1.77 million patients worldwide received dialysis. Of these patients, 1.58 million were treated with hemodialysis and approximately 190,000 received peritoneal dialyisis. In a ...

Kidney disease impacts millions globally. Two main treatments, hemodialysis and peritoneal dialysis, offer life-saving solutions. Hemodialysis uses a machine to filter blood, while peritoneal dialysis ...